Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-01-09

FDA Approved: FEBUXOSTAT — Original Application (Zydus Lifesciences Limited)

View source ↗

Summary

FDA approved Zydus Lifesciences Limited's febuxostat Original Application, granting approval for a generic febuxostat product. Febuxostat is indicated for the c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FEBUXOSTAT (Febuxostat)

Snippet

ORIG AP for FEBUXOSTAT (FEBUXOSTAT)